Protalix BioTherapeutics, Inc. (PLX) Financials

PLX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 110.3 million 38.9 million
March 31, 2026 102.3 million 35.1 million
Dec. 31, 2025 82.3 million 34.1 million
Sept. 30, 2025 82.3 million 29.4 million

PLX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -11.0 million 398000
March 31, 2026 21.3 million 532000
Dec. 31, 2025 1.6 million 732000
Sept. 30, 2025 -4.2 million 598000

PLX Net Income

No data available :(

PLX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 40.7 million - 9.2 million
March 31, 2026 51.8 million - 7.0 million
Dec. 31, 2025 30.3 million - 8.3 million
Sept. 30, 2025 29.4 million - 8.2 million

PLX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 82.6 million
March 31, 2026 83.0 million
Dec. 31, 2025 78.5 million
Sept. 30, 2025 80.8 million

PLX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 593000 4.4 million 3.1 million -
March 31, 2026 761000 5.4 million 3.1 million 7.4 million
Dec. 31, 2025 403000 5.6 million 3.5 million 8.7 million
Sept. 30, 2025 498000 4.5 million 2.9 million 17.7 million

PLX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 19.9 million 7.8 million
March 31, 2026 33.8 million 4.1 million
Dec. 31, 2025 9.1 million 4.6 million
Sept. 30, 2025 17.9 million 8.3 million

PLX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PLX

Price: $2.62

52 week price:
1.60
3.19

Earnings Per Share: 0.23 USD

P/E Ratio: 10.17

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 637200

Market Capitalization: 220.0 million

Links: